Systemic and regional effects of vasoactive drugs;Systemische und regionale effekte vasoaktiver substanzen

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 48, 2004, Pages 2616-2620

  Meier Hellmann, A ^a  

^a HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; NORADRENALIN; VASOACTIVE AGENT; VASOPRESSIN;

DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; HUMAN; PHARMACODYNAMICS; REVIEW;

DOPAMINE; HUMANS; REPRODUCIBILITY OF RESULTS; SHOCK, SEPTIC; VASODILATOR AGENTS;

EID: 9944224313     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-836087     Document Type: Review

References (44)

1. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139-2143
2. Bersten AD, Hersch M, Cheung H, Rutledge FS, Sibbald WJ. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery 1992; 112: 549-561
3. Bollaert PE, Bauer P, Audibert G, Lambert H, Larcan A. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990; 98: 949-953
4. Burchardi H, Briegel J, Eckart J et al. Expertenforum: Hämodynamisch aktive Substanzen in der Intensivmedizin. Anästhesiologie & Intensivmedizin 2000; 41: 562-631
5. De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003; 31: 1659-1667
6. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-555
7. Desjars P, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17: 426-429
8. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15: 134-137
9. Di Giantomasso D, Morimatsu H, May CN, Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med 2003; 31: 2509-2513
10. Dive A, Foret F, Jamart J, Bulpa P, Installe E. Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 2000; 26: 901-907
11. Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 1994; 22: 1919-1925
12. Dunser MW, Mayr AJ, Ulmer H et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001; 93: 7-13
13. Giraud GD, MacCannell KL. Decreased nutrient blood flow during dopamine- and epinephrine- induced intestinal vasodilation. J Pharmacol Exp Ther 1984; 230: 214-220
14. Gutierrez G, Clark C, Brown SD et al. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Amer J Respir Crit Care Med 1994; 150: 324-329
15. Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989; 17: 179-180
16. Hollenberg SM, Ahrens TS, Astiz ME et al. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999; 27: 639-660
17. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001; 27: 1416-1421
18. Kern H, Schroder T, Kaulfuss M et al. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 2001; 29: 1519-1525
19. Kiefer P, Tugtekin I, Wiedeck H et al. Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock. Am J Respir Crit Care Med 2000; 161: 775-779
20. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003; 31: 2646-2650
21. Landry DW, Levin HR, Gallant EM et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95: 1122-1125
22. Leier CV. Regional blood flow responses to vasodilators and inotropes in congestive heart failure. Am J Cardiol 1988; 62: 86E-93E
23. Levy B, Bollaert PE, Charpentier C et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997; 23: 282-287
24. Levy B, Bollaert PE, Lucchelli JP et al. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med 1997; 25: 1649-1654
25. MacGregor DA, Prielipp RC, Butterworth JF, James RL, Royster RL. Relative efficacy and potency of beta-adrenoceptor agonists for generating cAMP in human lymphocytes. Chest 1996; 109: 194-200
26. Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E. The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 2003; 97: 1756-1763
27. Martin C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18: 282-285
28. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28: 2758-2765
29. Meier-Hellmann A, Bredle DL, Specht M, Hannemann L, Reinhart K. Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Crit Care Med 1999; 27: 2166-2171
30. Meier-Hellmann A, Bredle DL, Specht M et al. The effects of low dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997; 23: 31-37
31. Meier-Hellmann A, Reinhart K, Bredle DL et al. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997; 25: 399-404
32. Neviere R, Mathieu D, Chagnon JL, Lebleu N, Wattel F. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996; 154: 1684-1688
33. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359: 1209-1210
34. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96: 576-582
35. Prielipp RC, MacGregor DA, Royster RL et al. Dobutamine antagonizes epinephrine's biochemical and cardiotonic effects: results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery. Anesthesiology 1998; 89: 49-57
36. Reinelt H, Radermacher P, Fischer G et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997; 86: 818-824
37. Silverman HJ, Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992; 102: 184-188
38. Sprung CL, Bernard GR, Dellinger RP. Guidelines for the management of severe sepsis and septic shock. Intensive Care Med 2001; 27: 1-134
39. Tsuneyoshi I, Yamada H, Kakihana Y et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487-493
40. Uusaro A, Ruokonen E, Takala J. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 1995; 74: 149-154
41. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996; 24: 1580-1590
42. van Haren FM, Rozendaal FW, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003; 124: 2256-2260
43. Varga C, Pavo I, Lamarque D et al. Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. Eur J Pharmacol 1998; 352: 257-261
44. Vincent JL, Van der Linden P, Domb M et al. Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration. Anesth Analg 1987; 66: 565-571